| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| 2-(biphenyl-4-ylsulfonyl)n-hydroxybenzamide | matrix metalloproteinase-12 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 2-(biphenyl-4-ylsulfonyl)n-hydroxybenzamide | matrix metalloproteinase-13 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 2-(biphenyl-4-ylsulfonyl)n-hydroxybenzamide | matrix metalloproteinase-14 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 2-(biphenyl-4-ylsulfonyl)n-hydroxybenzamide | matrix metalloproteinase-2 | NA | Successful target | TTD | NA | NA | investigative | unknown |
| 2-(biphenyl-4-ylsulfonyl)n-hydroxybenzamide | matrix metalloproteinase-8 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| 2-(biphenyl-4-ylsulfonyl)n-hydroxybenzamide | matrix metalloproteinase-9 | NA | Clinical trial target | TTD | NA | NA | investigative | unknown |
| click here to return to the previous page | ||||||||